Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2018 1
2019 4
2020 2
2021 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.
Yarchoan M, Cope L, Ruggieri AN, Anders RA, Noonan AM, Goff LW, Goyal L, Lacy J, Li D, Patel AK, He AR, Abou-Alfa GK, Spencer K, Kim EJ, Davis SL, McRee AJ, Kunk PR, Goyal S, Liu Y, Dennison L, Xavier S, Mohan AA, Zhu Q, Wang-Gillam A, Poklepovic A, Chen HX, Sharon E, Lesinski GB, Azad NS. Yarchoan M, et al. Among authors: dennison l. J Clin Invest. 2021 Dec 15;131(24):e152670. doi: 10.1172/JCI152670. J Clin Invest. 2021. PMID: 34907910 Free PMC article. Clinical Trial.
Effects of B cell-activating factor on tumor immunity.
Yarchoan M, Ho WJ, Mohan A, Shah Y, Vithayathil T, Leatherman J, Dennison L, Zaidi N, Ganguly S, Woolman S, Cruz K, Armstrong TD, Jaffee EM. Yarchoan M, et al. Among authors: dennison l. JCI Insight. 2020 May 21;5(10):e136417. doi: 10.1172/jci.insight.136417. JCI Insight. 2020. PMID: 32434989 Free PMC article.
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones.
Karthikeyan S, Waters IG, Dennison L, Chu D, Donaldson J, Shin DH, Rosen DM, Gonzalez-Ericsson PI, Sanchez V, Sanders ME, Pantone MV, Bergman RE, Davidson BA, Reed SC, Zabransky DJ, Cravero K, Kyker-Snowman K, Button B, Wong HY, Hurley PJ, Croessmann S, Park BH. Karthikeyan S, et al. Among authors: dennison l. J Clin Invest. 2021 Mar 15;131(6):e143557. doi: 10.1172/JCI143557. J Clin Invest. 2021. PMID: 33529175 Free PMC article.
HoxA9 binds and represses the Cebpa +8 kb enhancer.
Peng L, Guo H, Ma P, Sun Y, Dennison L, Aplan PD, Hess JL, Friedman AD. Peng L, et al. Among authors: dennison l. PLoS One. 2019 May 23;14(5):e0217604. doi: 10.1371/journal.pone.0217604. eCollection 2019. PLoS One. 2019. PMID: 31120998 Free PMC article.
MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity.
Yarchoan M, Mohan AA, Dennison L, Vithayathil T, Ruggieri A, Lesinski GB, Armstrong TD, Azad NS, Jaffee EM. Yarchoan M, et al. Among authors: dennison l. PLoS One. 2019 Oct 31;14(10):e0224600. doi: 10.1371/journal.pone.0224600. eCollection 2019. PLoS One. 2019. PMID: 31671149 Free PMC article.
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties.
Kyker-Snowman K, Hughes RM, Yankaskas CL, Cravero K, Karthikeyan S, Button B, Waters I, Rosen DM, Dennison L, Hunter N, Donaldson J, Christenson ES, Konstantopoulos K, Hurley PJ, Croessmann S, Park BH. Kyker-Snowman K, et al. Among authors: dennison l. Breast Cancer Res Treat. 2020 Feb;179(3):631-642. doi: 10.1007/s10549-019-05506-3. Epub 2019 Dec 10. Breast Cancer Res Treat. 2020. PMID: 31823098 Free PMC article.
11 results